Lv41
530 积分 2021-03-01 加入
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
32分钟前
已完结
A PSMA-Targeting CD3 Bispecific Antibody Induces Antitumor Responses that Are Enhanced by 4-1BB Costimulation
21天前
已完结
HER3 upregulation reduces DS-8201 sensitivity in HER2-positive tumor cells by ATR/CHK1/FoxO1 signaling cascade
1个月前
已完结
Preclinical Activity of SAR408701: A Novel Anti-CEACAM5–maytansinoid Antibody–drug Conjugate for the Treatment of CEACAM5-positive Epithelial Tumors
2个月前
已完结
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
2个月前
已完结
Peripheral T cell expansion predicts tumour infiltration and clinical response
2个月前
已完结
Effects of Drug–Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody–Maytansinoid Conjugates
2个月前
已完结
First-Line Immunotherapy for Non-Small-Cell Lung Cancer
3个月前
已完结
Design, synthesis and antitumor evaluation of a novel nectin-4 targeting bicyclic toxin conjugate
3个月前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
4个月前
已完结
皖公网安备34019202002308
